745
Views
11
CrossRef citations to date
0
Altmetric
Case Reports

Piperacillin/tazobactam-induced neutropenia, thrombocytopenia, and fever during treatment of a diabetic foot infection

, , , , &
Pages 73-76 | Received 14 May 2012, Accepted 21 May 2012, Published online: 01 Jul 2012

References

  • Lipsky BA, Berendt AR, Embil J, De Lalla F.Diagnosing and treating diabetic foot infections.Diabetes Metab Res Rev2004;20:S56–64.
  • Reichardt P, Handrick W, Linke A, Schille R, Kiess W.Leukocytopenia, thrombocytopenia and fever related to piperacillin/tazobactam treatment—a retrospective analysis in 38 children with cystic fibrosis.Infection1999;27:355–6.
  • Pérez-Vázquez A, Pastor JM, Riancho JA.Immune thrombocytopenia caused by piperacillin/tazobactam.Clin Infect Dis1998;27:650–1.
  • Gerber L, Wing EJ.Life-threatening neutropenia secondary to piperacillin/tazobactam therapy.Clin Infect Dis1995;21: 1047–8.
  • Ruiz-irastorza G, Barreiro G, Aguirre C.Reversible bone marrow depression by high-dose piperacillin/tazobactam.Br J Haematol1996;95:611–2.
  • Behbahani R, Kostman JR.Hypersensitivity reaction during prolonged use of piperacillin/tazobactam in treatment of osteomyelitis.Ann Pharmacother1995;29:936–7.
  • Peralta FG, Sánchez MB, Roíz MP, Pena MA, Tejero MA, Arjona R.Incidence of neutropenia during treatment of bone-related infections with piperacillin–tazobactam.Clin Infect Dis2003;37:1568–72.
  • Scheetz MH, McKoy JM, Parada JP, Djulbegovic B, Raisch DW, Yarnold PR, et al.Systematic review of piperacillin-induced neutropenia.Drug Saf2007;30: 295–306.
  • Perry CM, Markham A.Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections.Drugs1999;57:805–43.
  • Neftel KA, Hauser SP, Müller MR.Inhibition of granulopoiesis in vivo and in vitro by beta-lactam antibiotics.J Infect Dis1985;152:90–8.
  • Patel RA, Gallagher JC.Drug fever.Pharmacotherapy2010;30:57–69.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.